chr17-49969745-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_138281.3(DLX4):āc.277G>Cā(p.Glu93Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000246 in 1,592,602 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_138281.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DLX4 | ENST00000240306.5 | c.277G>C | p.Glu93Gln | missense_variant | 1/3 | 1 | NM_138281.3 | ENSP00000240306.3 | ||
DLX4 | ENST00000503410.1 | n.201G>C | non_coding_transcript_exon_variant | 2/4 | 4 | |||||
DLX4 | ENST00000505318.2 | n.416G>C | non_coding_transcript_exon_variant | 1/2 | 3 | |||||
DLX4 | ENST00000706528.1 | n.1158G>C | non_coding_transcript_exon_variant | 1/3 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152064Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.000304 AC: 70AN: 229924Hom.: 0 AF XY: 0.000366 AC XY: 46AN XY: 125672
GnomAD4 exome AF: 0.000249 AC: 359AN: 1440420Hom.: 0 Cov.: 32 AF XY: 0.000261 AC XY: 187AN XY: 716580
GnomAD4 genome AF: 0.000210 AC: 32AN: 152182Hom.: 0 Cov.: 30 AF XY: 0.000228 AC XY: 17AN XY: 74410
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 30, 2021 | The c.277G>C (p.E93Q) alteration is located in exon 1 (coding exon 1) of the DLX4 gene. This alteration results from a G to C substitution at nucleotide position 277, causing the glutamic acid (E) at amino acid position 93 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at